Skip to main content
TipRanks
Go Ultimate75% OFF

Anavex Life Sciences (AVXL) Ownership - Who Owns Anavex Life Sciences?

1,758 Followers

Anavex Life Sciences (AVXL) Ownership Overview

  • 1.66% Insiders
  • 10.55% Mutual Funds
  • 13.27% Other Institutional Investors
  • 11.44% ETFs
  • 63.07% Public Companies and Individual Investors

The ownership structure of Anavex Life Sciences (AVXL) stock is a mix of institutional, retail, and individual investors. Approximately 35.27% of the company’s stock is owned by Institutional Investors, 1.66% is owned by Insiders, and 63.07% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Sep 30, 2026 $16,451,177
Sep 30, 2026Gmt Capital Corp$5,462,815

Top Shareholders

AVXL top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.8,144,147Institution8.79%5,855,642
Ishares4,849,947Institution5.23%3,487,112
Vanguard4,295,798Institution4.63%3,088,679
Vanguard Index Funds3,966,953Institution4.28%2,852,239
Thomas E. Claugus2,704,364Institution2.92%1,944,438
Federated Hermes Mdt Series2,045,098Institution2.21%1,470,425
Christopher Missling1,510,165Insider1.63%1,085,809
Fidelity Salem Street Trust1,129,534Institution1.22%812,135
Fidelity Concord Street Trust838,374Institution0.90%602,791
Vanguard Scottsdale Funds622,810Institution0.67%447,800

Top Mutual Fund Holders

AVXL top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds3,966,953Institution4.28%2,852,239
Federated Hermes Mdt Series2,045,098Institution2.21%1,470,425
Fidelity Salem Street Trust1,129,534Institution1.22%812,135
Fidelity Concord Street Trust838,374Institution0.90%602,791
Vanguard Scottsdale Funds622,810Institution0.67%447,800
Tiaa-cref Funds312,085Institution0.34%224,389
Vanguard World Fund270,423Institution0.29%194,434
Schwab Capital Trust224,867Institution0.24%161,679
Bridgeway Funds, Inc.123,000Institution0.13%88,437
Vanguard Valley Forge Funds48,976Institution0.05%35,214

Top ETF Holders

AVXL top ETF holders
Holder# of SharesType% HoldingValue
iShares Russell 2000 ETF, IWM ETF2,430,246Institution2.62%1,748,319
Vanguard Total Stock Market ETF, VTI ETF2,305,349Institution2.49%2,743,365
Vanguard Extended Market ETF, VXF ETF1,081,833Institution1.17%1,287,381
iShares Russell 2000 Value ETF, IWN ETF736,898Institution0.79%530,124
iShares Biotechnology ETF, IBB ETF703,136Institution0.76%505,836
Vanguard Russell 2000 ETF, VTWO ETF543,863Institution0.59%647,197
Schwab U.S. Small-Cap ETF, SCHA ETF492,979Institution0.53%364,804
iShares Micro-Cap ETF, IWC ETF279,034Institution0.30%200,737
Vanguard Health Care ETF, VHT ETF271,823Institution0.29%323,469
iShares Russell 2000 Growth ETF, IWO ETF204,978Institution0.22%147,461

FAQ

Who Owns Anavex Life Sciences (AVXL)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 35.27% of the company's stock is held by institutional investors, 1.66% is held by insiders, and 63.07% is held by public companies and individual investors.
What percentage of Anavex Life Sciences (AVXL) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 35.27% of Anavex Life Sciences (AVXL) stock is held by institutional investors: 10.55% by mutual funds, 11.44% by ETFs and 13.27% by other institutional investors.
What percentage of Anavex Life Sciences (AVXL) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 63.07% of Anavex Life Sciences (AVXL) stock is held by public companies and individual investors.
Who owns the most shares of Anavex Life Sciences (AVXL)?
BlackRock, Inc. owns the most shares of Anavex Life Sciences (AVXL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.